secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2022-09-09T23:59:59+00:00
Accession:  0001193125-22-241970
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics restructures Novartis license milestone payments, issues ~$7M in stock
--------------------------------------------------------------------------------

- Amended license with Novartis for MAU868; capped total milestone payments at $62.0M.
- Issuing 283,034 shares of Class A common stock to Novartis, valued at ~$7M based on closing price plus 20% premium.
- Share issuance expected to close on or about September 13, 2022.
- Modification adjusts development and regulatory milestone payment structure under the existing license.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312522241970/0001193125-22-241970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312522241970/d265248d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-241970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer